Fampyra 10 mg Norveġja - Norveġiż - Statens legemiddelverk

fampyra 10 mg

orifarm as - fampridin - depottablett - 10 mg

Mitoxantron Ebewe 2 mg/ ml Norveġja - Norveġiż - Statens legemiddelverk

mitoxantron ebewe 2 mg/ ml

ebewe pharma ges.m.b.h nfg. kg - mitoksantronhydroklorid - konsentrat til infusjonsvæske, oppløsning - 2 mg/ ml

Novantrone 2 mg/ ml Norveġja - Norveġiż - Statens legemiddelverk

novantrone 2 mg/ ml

viatris as - mitoksantronhydroklorid - konsentrat til infusjonsvæske, oppløsning - 2 mg/ ml

Zeposia Unjoni Ewropea - Norveġiż - EMA (European Medicines Agency)

zeposia

bristol-myers squibb pharma eeig - ozanimod hydrochloride - multiple sclerosis, relapsing-remitting; colitis, ulcerative - immunsuppressive - multiple sclerosiszeposia is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (rrms) with active disease as defined by clinical or imaging features. ulcerative colitiszeposia is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis (uc) who have had an inadequate response, lost response, or were intolerant to either conventional therapy or a biologic agent.

Fampridine Accord Unjoni Ewropea - Norveġiż - EMA (European Medicines Agency)

fampridine accord

accord healthcare s.l.u. - fampridine - multippel sklerose - andre nervesystemet narkotika - fampridine accord is indicated for the improvement of walking in adult patients with multiple sclerosis with walking disability (edss 4-7).

Mavenclad 10 mg Norveġja - Norveġiż - Statens legemiddelverk

mavenclad 10 mg

orifarm as - kladribin - tablett - 10 mg

Fampridine Sandoz 10 mg Norveġja - Norveġiż - Statens legemiddelverk

fampridine sandoz 10 mg

sandoz a/s - fampridin - depottablett - 10 mg